Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH.

José R González PorrasJ MateoV Gonzalez-CalleP MarcoV Garcia-GutierrezJ C ReverterR Lecumberri

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)

Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.

Keyphrases

venous thromboembolism
direct oral anticoagulants
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
clinical practice
case control